⏳ Fetching live dividend data...
Home › Calculator › EXAS Dividend Calculator 2026
Exact Sciences Corporation · NASDAQ
Price: $104.91 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in EXAS → $2.67M in 10 years · $16.29/month
Exact Sciences Corporation specializes in developing and distributing cancer screening and diagnostic tools across the United States and internationally. Their key product, Cologuard, is an innovative, non-invasive test that analyzes stool-based DNA to identify specific DNA and hemoglobin biomarkers indicative of colorectal cancer and precancerous conditions. The company's extensive portfolio also includes the Oncotype DX family of gene expression tests, designed for breast, prostate, and colon cancers. Within this suite, the Oncotype Test provides detailed tumor profiling from tissue samples, assisting in treatment selection for individuals battling advanced, metastatic, refractory, or recurrent cancers. Furthermore, they offer the Oncotype DX AR-V7 Nucleus Detect Test, a liquid biopsy designed for advanced-stage prostate cancer patients, and Oncomap ExTra, which delivers a comprehensive biological insight into challenging, rare, or aggressive malignancies. Exact Sciences also provides COVID-19 testing services. Future initiatives involve enhancing Cologuard's performance characteristics and pioneering novel blood- and other fluid-based diagnostic tests. The company maintains important license agreements with the MAYO Foundation for Medical Education and Research and Hologic, Inc. Established in 1995, Exact Sciences Corporation's corporate headquarters are located in Madison, Wisconsin.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open EXAS position with:
Real after-tax yield depends on where you live and how you hold EXAS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.91% | -0.89% | $191 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.62% | -1.18% | $162 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.53% | -1.27% | $153 / yr |
| 🇬🇧 UK ISA | 0% | 1.91% | -0.89% | $191 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.74% | -1.06% | $174 / yr |
| 🇨🇦 TFSA | 0% | 1.91% | -0.89% | $191 / yr |
| 🇨🇦 CA Taxable | 25% | 1.43% | -1.37% | $143 / yr |
| 🇦🇺 Super (pension) | 15% | 1.62% | -1.18% | $162 / yr |
| 🇦🇺 AU Taxable | 30% | 1.34% | -1.46% | $134 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.41% | -1.39% | $141 / yr |
| 🇫🇷 FR Taxable | 30% | 1.34% | -1.46% | $134 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
EXAS pays quarterly — 4 times per year. Next ex-div: TBD.
How EXAS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for EXAS sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-03-23 | 33,321 | — | — | ||
| D-Return | 2026-03-23 | 795 | — | — | ||
| D-Return | 2026-03-23 | 28,063 | — | — | ||
| D-Return | 2026-03-23 | 1,762 | $0.01 | $18.00 | ||
| D-Return | 2026-03-23 | 793 | $92.62 | $73.4K | ||
| D-Return | 2026-03-23 | 2,861 | $98.18 | $280.9K | ||
| D-Return | 2026-03-23 | 20,321 | — | — | ||
| A-Award | 2026-03-23 | 89,911 | — | — | ||
| D-Return | 2026-03-23 | 417 | — | — | ||
| D-Return | 2026-03-23 | 28,063 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the EXAS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Exact Sciences Corporation (EXAS) is currently trading at $104.91, 25% below its 52-week high. The current dividend yield is 1.91% based on an annual payout of $2.00 per share.
Exact Sciences Corporation (EXAS) is a healthcare stock currently trading at $104.91 with a dividend yield of 1.91%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever